Key facts
- It has raised $4.5M; the latest was Seed Round ($4.5M) in Oct 2025.
- Notable investors include Seedcamp, City Light Capital, Lightbank (Venture Capital), SemperVirens Venture Capital, Bertelsmann Investments — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Andel
- ·The full record, as it builds
Funding rounds
No funding rounds for Andel are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Andel
Provider of a pharmacy benefit and membership service designed to create an equitable way for groups to access life-saving medications. The company aggregates the collective purchasing power of its members, creating a system that provides access to crucial drugs at an affordable price than is typically available through traditional insurance or individual cash payments, enabling plan sponsors and individuals to bypass the limitations of conventional healthcare financing and obtain essential medications without the burden of prohibitive costs.
- Sector
- Healthcare
- HQ
- New York, NY, United States
- Founded
- 2025
- Website
- andel.org/
- Ownership
- Privately Held (backing)
Andel doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Andel shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Andel in its N-PORT filings yet. We sweep new filings monthly.